Quintin Cassady, vice president and general counsel of Galderma Laboratories L.P.
Quintin Cassady, vice president and general counsel of Galderma Laboratories L.P. (Courtesy photo)

Covering corporate law depart­ments and in-house attorneys for Texas Lawyer and other ALM publications, reporter Kristen Rasmussen profiles Quintin Cassady, vice president and general counsel at Galderma Laboratories.

Headquartered in Lausanne, Switzerland, Galderma is the operating company of Nestlé Skin Health and the maker of Cetaphil and Restylane, among many well-known skin care products. Galderma was created from a joint venture between Nestlé and L’Oréal in 1981 and is now present in more than 100 countries. It was fully acquired by Nestlé in 2014. The company specializes in the research, development and marketing of dermatological treatments.There are four buildings, including a distribution center, on the campus of the company’s U.S. headquarters in Fort Worth.


Cassady oversees a five-attorney legal department that is responsible for Galderma’s North American markets, including Canada. The legal team, he added, is “set up in a functional aspect,” with attorneys responsible for the legal issues associated with discrete business units, including prescription, consumer and aesthetic and corrective dermatology.

Although about 80 percent of the work is kept in-house, Cassady said he outsources specialty work including mergers and acquisitions, and ERISA matters, regulatory issues and litigation.The team manages the litigation, however, particularly patent cases, “very closely.”

“We are more involved in the patent cases than most of the lawyers we use,” Cassady said. “They may be the ones doing the appearance, but I am very hands-on.”


For patent litigation or litigation involving the Hatch-Waxman Act—the federal law that governs the regulation of generic drugs—Cassady turns to Paul Hastings and Dallas-based Munck Wilson Mandala.

He uses Mayer Brown for M&A work, certain types of litigation, especially cases in California, and general matters. For employment and ERISA issues, Cassady brings in Dallas-based Haynes and Boone.


In addition to running Galderma’s legal department, Cassady also supervises a health care compliance team, made up of one lawyer and six other individuals, which manages interactions with health care professionals. He also serves on the leadership team for North America, where he negotiates and integrates new products and company acquisitions, and oversees risk management and facility matters.

“What really makes my job fun is the international nature of the business,” Cassady said. “I have a lot of interaction with my legal compliance colleagues around the world and, during my tenure here, I’ve had the opportunity to work for presidents [for North America] who were Brazilian, Dutch, French and English. It just makes things really interesting for me.”


An Oklahoma native, Cassady holds degrees from the University of Oklahoma and the school’s College of Law. He joined Galderma in 2000 as associate general counsel and was promoted to the top position the following year. Prior to going in-house at the international dermatology company, Cassady was a partner at the defunct Shannon, Gracey, Ratliff & Miller and, prior to that, legal counsel for the University of North Texas Health Science Center in Fort Worth for four years.


Cassady and his wife, whom he met in law school, have been married for 25 years and have two children: a son who is a junior at OU and a daughter who is a senior at Fort Worth Country Day School. He said he enjoys golf and activities that involve his kids.


“Marina,” by Carlos Ruiz Zafón, a Gothic novel set in old Barcelona, Spain, from late 1979 to May 1980 that centers on a 15-year-old student’s journey after he vanishes from his boarding school for seven days and nights. Cassady said he read the novel in advance of a family trip this summer to Spain, where his fluently Spanish-speaking son was studying abroad.

“I really like reading about or having a sense of the culture that I visit,” he said.